5 Key Takeaways
-
1
The SEE program significantly improved medication adherence in glaucoma patients compared to standard written education.
-
2
Participants in the SEE group achieved a mean adherence of 77.6%, while controls had 58.0% adherence.
-
3
Over half of SEE participants reached at least 80% adherence, compared to only 23.7% of control participants.
-
4
The SEE intervention also reduced glaucoma-related distress, particularly emotional burden and regimen-related distress.
-
5
The study supports multifaceted, personalized adherence interventions as more effective than single-component strategies.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
